Avalon's Laboratory Services MSO Launches DNA Testing Kit For Predisposition To Opioid Addiction
Portfolio Pulse from Benzinga Newsdesk
Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC, in which Avalon holds a 40% equity interest, has launched a direct-to-consumer DNA test for predisposition to opioid addiction.
July 31, 2024 | 12:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Avalon GloboCare Corp. (NASDAQ:ALBT) has announced that Laboratory Services MSO, LLC, in which it holds a 40% equity interest, has launched a new DNA test for opioid addiction predisposition.
The launch of a new DNA test for opioid addiction predisposition by Laboratory Services MSO, LLC, in which Avalon holds a significant equity interest, could drive growth and investor interest in Avalon GloboCare. This new product expands their portfolio in the precision diagnostics market.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80